A multicenter study links an elevated blood urea nitrogen (BUN) to albumin ratio with higher 28- and 90-day mortality in critically ill older patients receiving continuous renal replacement therapy (CRRT). The work focuses on baseline risk stratification using a marker that is readily available in clinical labs. If validated prospectively, the BUN-to-albumin ratio could support earlier prognostic identification and may help clinicians refine monitoring intensity and care planning. The study also highlights how albumin levels can influence interpretation of renal function markers in critically ill patients. The findings add to the body of evidence seeking pragmatic bedside predictors for severe kidney injury outcomes.
Get the Daily Brief